We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Vectura’s portfolio currently includes 13 inhaled and 11 noninhaled products sold by different marketing partners, including Novartis, GlaxoSmithKline and Bayer. Read More
The company said that the CE marks cover broad indications for its Fibergraft BG Putty and BG Morsels products for fusion procedures in the lumbar and anterior cervical spine. Read More